Icon Plc, a Dublin-headquartered clinical researcher for pharmaceutical firms, is facing a potential US court battle over ...

ICON has seen a decline in its non-current bank and loan debts of 36.88% since 2021. Click here to find out why ICLR stock is ...

New York, New York-- (Newsfile Corp. - February 28, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, ...

A laboratory setting with a team of scientists working on a clinical trial. Number of Hedge Fund Holders: 48 ICON Public Limited Company (NASDAQ:ICLR) provides outsourced clinical research and ...

DUBLIN, January 30, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its ...

Irish-headquartered clinical research organisation ICON plc is facing a class action lawsuit in the US over allegations that ...

Icon plc has launched a new buyback program to repurchase up to $750 million of its shares. The total value of the authorized share repurchase is now up to $1 billion, the healthcare intelligence and ...

In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against other AI news and ratings too important to miss. Artificial intelligence is rapidly ...